Pila Pharma AB (PILA)

Stockholm

Currency in SEK

2.20

-0.04(-1.79%)

Closed·22/08

Fair Value

Unlock Value

Day's Range

2.17

2.35

52 wk Range

2.17

6.40

PILA Financial Summary

A brief financial summary of Pila Pharma AB as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

Key Ratios

P/E Ratio-6.92

Price/Book15.75

Debt / Equity166.67%

Return on Equity-188.57%

Dividend Yield0.00%

EBITDA-7.03M

Fair ValueUnlock

Fair Value UpsideUnlock

Statements Highlights

Period Ending:

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

Income Statement

Total Revenues

aa.aa

0.72

1.88

1.46

0.79

Gross Profit

aa.aa

-0.49

0.68

1.88

1.46

0.79

Operating Income

aa.aa

-3.38

-9.26

-8.89

-6.39

-8.11

Net Income

aa.aa

-6.98

-17.21

-26.78

-9.93

-11.24

Balance Sheet

Total Assets

aa.aa

5.37

31.81

10.89

8.46

6.22

Total Current Liabilities

aa.aa

1.95

1.51

1.36

1.79

0.96

Total Equity

aa.aa

3.42

30.3

9.53

6.66

5.26

Cash Flow

Levered Free Cash Flow

aa.aa

-0.73

-5.88

-5.76

-2.44

-4.66

Cash from Operations

aa.aa

-2

-9.36

-9.09

-4.85

-7.82

Cash from Investing

aa.aa

Cash from Financing

aa.aa

-0.16

35.67

-11.88

3.56

6.76

Net Change in Cash

aa.aa

-2.16

26.3

-20.97

-1.29

-1.06

* In Millions of SEK (except for per share items)

Earnings

Latest Release

Mar 27, 2025

EPS / Forecast

-0.26 / --

Revenue / Forecast

106.89K / --

EPS Revisions

Unlock

Last 90 days

FAQ

What were Pila Pharma AB's earnings for the latest quarter?

The Pila Pharma AB EPS (TTM) is -0.44. Pila Pharma AB reported sales of 0.11, net income of -7.16, and EPS of -0.26 for the latest quarter.

What was Pila Pharma AB's net income for the latest quarter?

Pila Pharma AB's net income for the latest quarter was -7.16.

How did Pila Pharma AB's performance compare year-over-year in the latest quarter?

The company's revenue moved from 0.68 in the previous quarter to 0.11 in the latest quarter, and net income moved from -4.09 to -7.16 compared to the previous quarter.

What is Pila Pharma AB's net profit margin on a TTM basis?

Pila Pharma AB's trailing twelve months (TTM) net profit margin is -1,423.15%.

How does Pila Pharma AB's debt to equity ratio compare to industry standards?

Pila Pharma AB's total debt-to-equity ratio is 166.67%.

What is Pila Pharma AB's return on investment on a TTM basis?

Pila Pharma AB's trailing twelve months (TTM) return on investment (ROI) is -188.57%.

Did Pila Pharma AB gain or lose cash last quarter?

In the latest quarter, Pila Pharma AB's net change in cash was 2.35 million.

What were Pila Pharma AB's total assets and liabilities in the latest quarter?

As of the latest quarter, Pila Pharma AB reported total assets of 6.22 million and total liabilities of 0.96 million.

How has Pila Pharma AB's total revenue grown this year?

Pila Pharma AB's total revenue was 0.68 in the previous quarter and 0.11 in the latest quarter.

What is Pila Pharma AB's gross margin on a TTM basis?

Pila Pharma AB's trailing twelve months (TTM) gross margin is 100.00%.

What was Pila Pharma AB's revenue per share for the latest quarter?

Pila Pharma AB's revenue per share for the latest quarter was 35.77.

NSE 30

5,139.93

+18.90

+0.37%

NSE All Share

141,004.14

+671.70

+0.48%

US 30

45,583.50

-48.2

-0.11%

US 500

6,459.00

-7.9

-0.12%

FTSE 100

9,321.40

+12.20

+0.13%

DAX

24,363.09

+69.75

+0.29%

South Africa Top 40

95,066.86

+946.46

+1.01%

Market Movers

Name	Last	Chg. %	Vol.
Fcmb	11.000	+2.33%	135.96M
Nigerian Breweries	70.00	+2.49%	43.26M
Transcorp Power	286.50	0.00%	29.76M
UBA	47.95	-0.10%	18.97M
Guaranty Trust Holding	94.00	+1.35%	15.99M
STANBIC IBTC Bank	94.00	-0.53%	13.33M
MTN Nigeria	435.00	0.00%	1.79M

Name	Last	Chg. %	Vol.
FTN Cocoa Processors PLC	6.60	+10.00%	2.67M
Betaglas	449.35	+10.00%	539.74K
UPDC	6.93	+10.00%	2.33M
Veritas Kapital	1.98	+10.00%	18.48M
Sovereign Trust Insurance Plc	2.65	+9.96%	19.48M
Ncr Nigeria	10.50	+9.95%	108.10K
Prestige	1.77	+9.94%	22.95M

Name	Last	Chg. %	Vol.
Thomaswy	3.00	-9.91%	1.35M
McNichols	3.20	-7.51%	3.39M
Initiates	12.30	-4.43%	2.23M
Etranz	10.850	-3.98%	481.90K
Npfmcrfbk	3.110	-2.81%	2.11M
Lafarge Africa	134.55	-1.82%	1.68M
Multverse	10.90	-0.91%	654.92K

Trending Stocks

Name	Last	Chg. %	Vol.
MTN Nigeria	435.00	0.00%	1.79M
Dangote Cement	520.00	0.00%	311.11K
Betaglas	449.35	+10.00%	539.74K
Aradel Holdings	519.00	0.00%	1.20M
Aiico	4.18	+6.63%	43.73M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaaa A	5,379.30	+45.28%	7,815.05
Aaaaaa Aaaaaa	520.00	+40.00%	728.00
Aaaaaa	1,890.00	+30.63%	2,468.91
Aaa Aaaaaaa	151.80	+27.76%	193.94
Aaaaaaaaa Aaaaaaa	70.20	+16.68%	81.91

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers

Popular Searches

Please try another search

Pila Pharma AB (PILA)

PILA Financial Summary

Key Ratios

Statements Highlights

Earnings

FAQ

What were Pila Pharma AB's earnings for the latest quarter?

What was Pila Pharma AB's net income for the latest quarter?

How did Pila Pharma AB's performance compare year-over-year in the latest quarter?

What is Pila Pharma AB's net profit margin on a TTM basis?

How does Pila Pharma AB's debt to equity ratio compare to industry standards?

What is Pila Pharma AB's return on investment on a TTM basis?

Did Pila Pharma AB gain or lose cash last quarter?

What were Pila Pharma AB's total assets and liabilities in the latest quarter?

How has Pila Pharma AB's total revenue grown this year?

What is Pila Pharma AB's gross margin on a TTM basis?

What was Pila Pharma AB's revenue per share for the latest quarter?

Trending Stocks